SEARCH

SEARCH BY CITATION

REFERENCES

  • Abramov E, Dolev I, Fogel H, Ciccotosto GD, Ruff E, Slutsky I (2009): Amyloid-beta as a positive endogenous regulator of release probability at hippocampal synapses. Nat Neurosci 12:15671576.
  • Aizenstein HJ, Nebes RD, Saxton JA, Price JC, Mathis CA, Tsopelas ND, Ziolko SK, James JA, Snitz BE, Houck PR, Bi W, Cohen AD, Lopresti BJ, DeKosky ST, Halligan EM, Klunk WE (2008): Frequent amyloid deposition without significant cognitive impairment among the elderly. Arch Neurol 65:15091517.
  • Aizenstein HJ, Nebes RD, Saxton JA, Price JC, Mathis CA, Tsopelas ND, Ziolko SK, James JA, Snitz BE, Houck PR, Bi W, Cohen AD, Lopresti BJ, DeKosky ST, Halligan EM, Klunk WE. (2008).Frequent amyloid deposition without significant cognitive impairment among the elderly. Arch Neurol,65:15091517.
  • Akaike H (1973): Information theory and an extension of the maximum likelihood principle. In: Petrov BN, Csaki F, editors. Proceedings of the Second International Symposium on Information Theory.Budapest:Akademiai Kiado. pp267281.
  • Alexander GE, Moeller JR (1994): Application of the Scaled Subprofile Model to functional imaging in neuropsychiatric disorders: A principal component approach to modeling brain function in disease. Hum Brain Mapp 2:7994.
  • Alexander GE, Chen K, Merkley TL, Reiman EM, Caselli RJ, Aschenbrenner M, et al. (2006): Regional network of magnetic resonance imaging gray matter volume in healthy aging. Neuroreport 17:951956.
  • Alexander GE, Chen K, Aschenbrenner M, Merkley TL, Santerre-Lemmon LE, Shamy JL, et al. (2008): Age-related regional network of magnetic resonance imaging gray matter in the rhesus macaque. J Neurosci 28:27102718.
  • Ashburner J, Friston KJ (1999): Nonlinear spatial normalization using basis functions. Hum Brain Mapp 7:254266.
  • Ashburner J, Neelin P, Collins DL, Evans A, Friston K (1997): Incorporating prior knowledge into image registration. Neuroimage 6:344352.
  • Becker JA, Hedden T, Carmasin J, Maye J, Rentz DM, Putcha D, et al. (2011): Amyloid-beta associated cortical thinning in clinically normal elderly. Ann Neurol 69:10321042.
  • Bennett DA, Schneider JA, Arvanitakis Z, Kelly JF, Aggarwal NT, Shah RC, et al. (2006): Neuropathology of older persons without cognitive impairment from two community-based studies. Neurology 66:18371844.
  • Benton AL, Hamsher K, Sivan AB (1983): Multilingual Aphasia Examination.Iowa City, IA:AJA Associates.
  • Bero AW, Yan P, Roh JH, Cirrito JR, Stewart FR, Raichle ME, et al. (2011): Neuronal activity regulates the regional vulnerability to amyloid-beta deposition. Nat Neurosci 14:750756.
  • Bourgeat P, Chetelat G, Villemagne VL, Fripp J, Raniga P, Pike K, et al. (2010): Beta-amyloid burden in the temporal neocortex is related to hippocampal atrophy in elderly subjects without dementia. Neurology 74:121127.
  • Braak H, Braak E (1991): Demonstration of amyloid deposits and neurofibrillary changes in whole brain sections. Brain Pathol 1:213216.
  • Buckner RL, Snyder AZ, Shannon BJ, LaRossa G, Sachs R, Fotenos AF, et al. (2005): Molecular, structural, and functional characterization of Alzheimer's disease: Evidence for a relationship between default activity, amyloid, and memory. J Neurosci 25:77097717.
  • Buckner RL, Sepulcre J, Talukdar T, Krienen FM, Liu H, Hedden T, et al. (2009): Cortical hubs revealed by intrinsic functional connectivity: Mapping, assessment of stability, and relation to Alzheimer's disease. J Neurosci 29:18601873.
  • Busche MA, Eichhoff G, Adelsberger H, Abramowski D, Wiederhold KH, Haass C, et al. (2008): Clusters of hyperactive neurons near amyloid plaques in a mouse model of Alzheimer's disease. Science 321:16861689.
  • Caselli RJ, Reiman EM, Osborne D, Hentz JG, Baxter LC, Hernandez JL, et al. (2004): Longitudinal changes in cognition and behavior in asymptomatic carriers of the APOE e4 allele. Neurology 62:19901995.
  • Chetelat G, Desgranges B, Landeau B, Mezenge F, Poline JB, de la Sayette V, et al. (2008): Direct voxel-based comparison between grey matter hypometabolism and atrophy in Alzheimer's disease. Brain 131 (Part 1):6071.
  • Cirrito JR, Yamada KA, Finn MB, Sloviter RS, Bales KR, May PC, et al. (2005): Synaptic activity regulates interstitial fluid amyloid-beta levels in vivo. Neuron 48:913922.
  • Cohen AD, Price JC, Weissfeld LA, James J, Rosario BL, Bi W, et al. (2009): Basal cerebral metabolism may modulate the cognitive effects of Abeta in mild cognitive impairment: An example of brain reserve. J Neurosci 29:1477014778.
  • Dale AM, Fischl B, Sereno MI (1999): Cortical surface-based analysis. I. Segmentation and surface reconstruction. Neuroimage 9:179194.
  • Delis DC, Kramer JH, Kaplan E, Ober BA (2000): California Verbal Learning Test, 2nd ed.San Antonio, TX:Psychological Corporation.
  • Desikan RS, Segonne F, Fischl B, Quinn BT, Dickerson BC, Blacker D, et al. (2006): An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage 31:968980.
  • Dickerson BC, Salat DH, Greve DN, Chua EF, Rand-Giovannetti E, Rentz DM, et al. (2005): Increased hippocampal activation in mild cognitive impairment compared to normal aging and AD. Neurology 65:404411.
  • Dickerson BC, Bakkour A, Salat DH, Feczko E, Pacheco J, Greve DN, et al. (2009): The cortical signature of Alzheimer's disease: Regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individuals. Cereb Cortex 19:497510.
  • Drzezga A, Becker JA, Van Dijk KR, Sreenivasan A, Talukdar T, Sullivan C, et al. (2011): Neuronal dysfunction and disconnection of cortical hubs in non-demented subjects with elevated amyloid burden. Brain 134 (Part 6):16351646.
  • Edison P, Archer HA, Hinz R, Hammers A, Pavese N, Tai YF, et al. (2007): Amyloid, hypometabolism, and cognition in Alzheimer disease: An [11C]PIB and [18F]FDG PET study. Neurology 68:501508.
  • Fellin T, Pascual O, Gobbo S, Pozzan T, Haydon PG, Carmignoto G (2004): Neuronal synchrony mediated by astrocytic glutamate through activation of extrasynaptic NMDA receptors. Neuron 43:729743.
  • Fischl B, Liu A, Dale AM (2001): Automated manifold surgery: Constructing geometrically accurate and topologically correct models of the human cerebral cortex. IEEE Trans Med Imaging 20:7080.
  • Fischl B, Salat DH, Busa E, Albert M, Dieterich M, Haselgrove C, et al. (2002): Whole brain segmentation: Automated labeling of neuroanatomical structures in the human brain. Neuron 33:341355.
  • Golden CJ (1978): Stroop Color and Word Test: A Manual for Clinical and Experimental Uses.Chicago:Stoelting.
  • Good CD, Johnsrude IS, Ashburner J, Henson RN, Friston KJ, Frackowiak RS (2001): A voxel-based morphometric study of ageing in 465 normal adult human brains. Neuroimage,14 (1 Part 1):2136.
  • Habeck C, Stern Y (2010): Multivariate data analysis for neuroimaging data: Overview and application to Alzheimer's disease. Cell Biochem Biophys 58:5367.
  • Habeck C, Krakauer JW, Ghez C, Sackeim HA, Eidelberg D, Stern Y, et al. (2005): A new approach to spatial covariance modeling of functional brain imaging data: Ordinal trend analysis. Neural Comput 17:16021645.
  • Habeck C, Foster NL, Perneczky R, Kurz A, Alexopoulos P, Koeppe RA, et al. (2008): Multivariate and univariate neuroimaging biomarkers of Alzheimer's disease. Neuroimage 40:15031515.
  • Hardy J, Selkoe DJ (2002): The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics. Science 297:353356.
  • Itagaki S, McGeer PL, Akiyama H, Zhu S, Selkoe D (1989): Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease. J Neuroimmunol 24:173182.
  • Jack CR Jr, Lowe VJ, Senjem ML, Weigand SD, Kemp BJ, Shiung MM, et al. (2008): 11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment. Brain 131:665680.
  • Jack CR Jr, Lowe VJ, Weigand SD, Wiste HJ, Senjem ML, Knopman DS, et al. (2009): Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: Implications for sequence of pathological events in Alzheimer's disease. Brain 132:13551365.
  • Jack CR Jr, Knopman DS, Jagust WJ, Shaw LM, Aisen PS, Weiner MW, et al. (2010): Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol 9:119128.
  • Jagust WJ, Mormino EC. (2011): Lifespan brain activity, beta-amyloid, and Alzheimer's disease. Trends Cogn Sci 15:520526.
  • Kadir A, Almkvist O, Forsberg A, Wall A, Engler H, Langstrom B, et al. (2012): Dynamic changes in PET amyloid and FDG imaging at different stages of Alzheimer's disease. Neurobiol Aging 33:198.e1198.e14.
  • Kamenetz F, Tomita T, Hsieh H, Seabrook G, Borchelt D, Iwatsubo T, et al. (2003): APP processing and synaptic function. Neuron 37:925937.
  • Kang JE, Lim MM, Bateman RJ, Lee JJ, Smyth LP, Cirrito JR, et al. (2009): Amyloid-beta dynamics are regulated by orexin and the sleep-wake cycle. Science 326:10051007.
  • Klunk WE, Engler H, Nordberg A, Wang Y, Blomqvist G, Holt DP, et al. (2004): Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann Neurol 55:306319.
  • Logan J, Fowler JS, Volkow ND, Wang GJ, Ding YS, Alexoff DL (1996): Distribution volume ratios without blood sampling from graphical analysis of PET data. J Cereb Blood Flow Metab 16:834840.
  • Mathis CA, Wang Y, Holt DP, Huang GF, Debnath ML, Klunk WE (2003): Synthesis and evaluation of 11C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents. J Med Chem 46:27402754.
  • Minoshima S, Giordani B, Berent S, Frey KA, Foster NL, Kuhl DE (1997): Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease. Ann Neurol 42:8594.
  • Moeller JR, Strother SC, Sidtis JJ, Rottenberg DA (1987): Scaled subprofile model: A statistical approach to the analysis of functional patterns in positron emission tomographic data. J Cereb Blood Flow Metab 7:649658.
  • Mormino EC, Kluth JT, Madison CM, Rabinovici GD, Baker SL, Miller BL, et al. (2009): Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects. Brain 132:13101323.
  • Mormino EC, Brandel MG, Madison CM, Marks S, Baker SL, Jagust WJ (2011): Aβ Deposition in Aging is Associated with Increases in Brain Activation during Successful Memory Encoding. Cereb Cortex. Epub ahead of print.
  • Oh H, Mormino EC, Madison C, Hayenga A, Smiljic A, Jagust WJ (2011): Beta-Amyloid affects frontal and posterior brain networks in normal aging. Neuroimage 54:18871895.
  • Oh H, Madison C, Haight TJ, Markley C, Jagust WJ (2012): Effects of age and beta-amyloid on cognitive changes in normal elderly people. Neurobiol Aging. Epub ahead of print.
  • Palop JJ, Mucke L (2009): Epilepsy and cognitive impairments in Alzheimer disease. Arch Neurol 66:435440.
  • Palop JJ, Mucke L (2010): Amyloid-beta-induced neuronal dysfunction in Alzheimer's disease: From synapses toward neural networks. Nat Neurosci 13:812818.
  • Pike KE, Savage G, Villemagne VL, Ng S, Moss SA, Maruff P, et al. (2007): Beta-amyloid imaging and memory in non-demented individuals: Evidence for preclinical Alzheimer's disease. Brain 130:28372844.
  • Price JC, Klunk WE, Lopresti BJ, Lu X, Hoge JA, Ziolko SK, et al. (2005): Kinetic modeling of amyloid binding in humans using PET imaging and Pittsburgh Compound-B. J Cereb Blood Flow Metab 25:15281547.
  • Puzzo D, Privitera L, Leznik E, Fa M, Staniszewski A, Palmeri A, et al. (2008): Picomolar amyloid-beta positively modulates synaptic plasticity and memory in hippocampus. J Neurosci 28:1453714545.
  • Reiman EM, Chen K, Alexander GE, Caselli RJ, Bandy D, Osborne D, et al. (2004): Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia. Proc Natl Acad Sci USA 101:284289.
  • Reitan RM (1958): Validity of the Trail Making Test as an indicator of organic brain damage. Percept Motor Skills 8:271276.
  • Segonne F, Dale AM, Busa E, Glessner M, Salat D, Hahn HK, et al. (2004): A hybrid approach to the skull stripping problem in MRI. Neuroimage 22:10601075.
  • Selkoe DJ (2001): Alzheimer's disease: Genes, proteins, and therapy. Physiol Rev 81:741766.
  • Silverman DH, Small GW, Chang CY, Lu CS, Kung De Aburto MA, Chen W, et al. (2001): Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome. JAMA 286:21202127.
  • Smith A (1982): Symbol Digits Modalities Test.Los Angeles, CA:Western Psychological Services.
  • Sorg C, Riedl V, Muhlau M, Calhoun VD, Eichele T, Laer L, et al. (2007): Selective changes of resting-state networks in individuals at risk for Alzheimer's disease. Proc Natl Acad Sci USA 104:1876018765.
  • Sperling RA, Laviolette PS, O'Keefe K, O'Brien J, Rentz DM, Pihlajamaki M, et al. (2009): Amyloid deposition is associated with impaired default network function in older persons without dementia. Neuron 63:178188.
  • Tosun D, Schuff N, Mathis CA, Jagust W, Weiner MW (2011): Spatial patterns of brain amyloid-beta burden and atrophy rate associations in mild cognitive impairment. Brain 134 (Part 4):10771088.
  • Vaishnavi SN, Vlassenko AG, Rundle MM, Snyder AZ, Mintun MA, Raichle ME (2010): Regional aerobic glycolysis in the human brain. Proc Natl Acad Sci USA 107:1775717762.
  • Vezzani A, Granata T (2005): Brain inflammation in epilepsy: Experimental and clinical evidence. Epilepsia 46:17241743.
  • Villemagne VL, Pike KE, Darby D, Maruff P, Savage G, Ng S, et al. (2008): Abeta deposits in older non-demented individuals with cognitive decline are indicative of preclinical Alzheimer's disease. Neuropsychologia 46:16881697.
  • Vlassenko AG, Vaishnavi SN, Couture L, Sacco D, Shannon BJ, Mach RH, et al. (2010): Spatial correlation between brain aerobic glycolysis and amyloid-beta (Abeta) deposition. Proc Natl Acad Sci USA 107:1776317767.
  • Wechsler D (1997): Wechsler Adult Intelligence Scale-III (WAIS-III) Manual.New York:The Psychological Corporation.
  • Yan P, Bero AW, Cirrito JR, Xiao Q, Hu X, Wang Y, et al. (2009): Characterizing the appearance and growth of amyloid plaques in APP/PS1 mice. J Neurosci 29:1070610714.